Gismo Therapeutics
PrivateLast Round
Grant
Aug 25, 2023
Total Funding Raised
$4.55M
Company Overview
Gismo Therapeutics is a biotechnology company developing first-in-class, disease-modifying oral therapeutics for the treatment of Alzheimer's and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gismo Therapeutics Comparables
Compare Gismo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Treventis Corporation | 83% | |
| Oligomerix, Inc. | 81% | |
| WaveBreak Therapeutics | 79% | |
Gismo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 25, 2023 | ||||
| Grant | Jun 16, 2022 | ||||
| Grant | Jun 14, 2019 | ||||
| Grant | Oct 12, 2017 | ||||
| Grant | Dec 3, 2014 |
Gismo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| U.S. Department of War | Grant |
| Kentucky Cabinet for Economic Development | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 46% MoM, reaching 1K.
- Oct 30, 2024
Monthly visitors grew 34% MoM, reaching 1K.
Gismo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gismo Therapeutics's valuation, stock price, and market status.